The field of medical diagnostics has endeavored to explore single species of biomolecules for sensitive and informative disease diagnostic applications. Here, Raman hyperspectroscopy is used to analyze red blood cells for identifying Celiac disease (CD). CD is a common autoimmune disorder which affects approximately 1% of the population. The ingestion of gluten by an individual with CD will result in the body initiating a violent immune response which causes severe damage to the small intestine. If the disease goes undiagnosed, substantial long-term health complications ranging in severity can arise. It is thus crucial to identify the disease as early on as possible to prevent additional problems from manifesting. However, current methods for detecting CD are expensive, invasive, and laborious. It was therefore the goal of this study to develop a better method for diagnosing CD which is noninvasive, inexpensive, accurate and definitive. Raman hyperspectroscopy was used to investigate individual red blood cells from donors with CD and from healthy controls who follow a gluten-free diet. FF-10101 in vitro Partial least squares discriminant analysis (PLS-DA) was used to evaluate the collected Raman spectral data for diagnostic purposes. Receiver operating characteristic (ROC) curve analysis was applied to evaluate the performance of the PLS-DA prediction algorithm, resulting in 100% successful external validation of the developed method at the donor level. Raman hyperspectroscopy in combination with chemometric analysis is shown herein to successfully evaluate red blood cells for the accurate detection of CD in a noninvasive, simple, and cost-effective manner.Linezolid and beta-lactams are anti-infective drugs frequently used in intensive care unit patients. Critical illness could induce alterations of pharmacokinetic parameters due to changes in the distribution, the metabolism and the elimination process. Therapeutic drug monitoring (TDM) is therefore recommended to prevent mainly under-dosing of beta-lactams or hematological and neurological toxicities of linezolid. In Multi-or Extensively-Drugs Resistant-Tuberculosis Bacteria, the regimen could include linezolid with meropenem and amoxicillin/clavulanate justifying the development of a method allowing their simultaneous quantification. The aim of this work was to develop an in-house ultra-performance liquid chromatography method with UV detection (UHPLC-PDA) allowing the simultaneous determination of 8 beta-lactams (amoxicillin, aztreonam, cefepime, ceftazidime, ceftriaxone, cefuroxime, meropenem and piperacillin) and linezolid and to cross-validate the linezolid quantification with a new commercial immunoassa50 mg/L for linezolid and 1-200 mg/L for other beta-lactams) with an intermediate precision and a relative bias below 7.6 and 7.7%, respectively. The analytical range of the immunoassay was narrower, from 0.85 to 18.5 mg/L. The precision and relative bias were lower than 8.1% and 4.2%, respectively. Results obtained on clinical samples showed an acceptable difference between methods with a mean bias of -1.8% [95% confidence interval -5.2% – 1.6%]. To conclude, both methods showed acceptable performance to perform TDM of linezolid considering the therapeutic through target of 2-8 mg/L. The choice of the method should be made according to the degree of emergency of the response required and the field of application justifying or not the simultaneous quantification of beta-lactams and linezolid.Simple, sensitive and rapid detection of circulating tumor cells (CTCs) is of great importance for early diagnosis and therapy of cancers. Overexpression of sugar units on cell surface is related to the phenotypes of many cancers. Based on the boronate ester interaction, we reported the electrochemical and colorimetric detection of CTCs with high simplicity and sensitivity. Specifically, ferroceneboronic acid (FcBA) can be measured by differential pulse voltammetry and 4-mercaptophenylboronic acid (MPBA) can induce the aggregation and color change of gold nanoparticles (AuNPs). CTCs captured by the aptamer-modified magnetic beads (Apt-MBs) can sequestrate FcBA or MPBA molecules by the formation of boronate ester bonds, thus leading to the decrease in the electrochemical signal of FcBA or preventing the MPBA-triggered aggregation of AuNPs. Due to the overexpression of sugar groups on the surface of CTCs, the amplification-free methods exhibited high sensitivity and obviated the use of additional antibody or aptamer for the recognition of captured cells. With MCF-7 cancer cell as the model, 50 cells can be readily determined by the electrochemical and colorimetric methods. The proposed strategy is valuable for probing of cell glycosylation and designing of novel sensing devices for detection of sugar-containing biological macromolecules and cells.Cyanide released from mostly industrial production is a highly toxic chemical. Its heavy industrial use and transportation increase the danger of human exposure. Since it can often lead to rapid death, selective, sensitive and on-site and rapid monitoring techniques for the detection of cyanide are essential. Therefore, we report an efficient cyanide probe based on thiazolium conjugated HBT-Br derivative. It has striking color change toward cyanide blue to yellow under daylight or colorless to cyan under UV-light. Interaction modes of the probe are based on ESIPT and ICT processes. It is selectively able to react free aqueous cyanide with detection limit of 1.79 μM, lower than physiologically lethal blood levels, >20 μM. Smartphone assisted and test kit applications are able to detect cyanide, qualitatively. Moreover, real samples such as tap or lake water and apricot seeds including cyanide are successfully determined through the present probe. Therefore, the designed probe displays excellent practical potential toward cyanide.A highly-enriched 233U reference material (>0.99987 n(233U)/n(U)) has been prepared and characterized for use as an isotope dilution mass spectrometry spike. An ion exchange separation was performed on 1 g of high purity 233U to further reduce trace amounts of contaminant Pu in the material. The purified 233U was then prepared as a master solution which was analyzed for molality of uranium by modified Davies and Gray titration. A portion of the master solution was quantitatively diluted and dispensed for reference material units. Selected units were analyzed for verification of uranium amount and to characterize uranium isotope amount ratios by multi-collector inductively couple plasma mass spectrometry. Modelling of spike-corrected isotopic data show that the new spike will enable simultaneous measurements of uranium amount and isotope amount ratios with resulting uncertainties that are substantially less sensitive to over spiking than widely used 233U certified reference materials.